ETFs Eurofins Scientific SE

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris Other stock markets 08:44:40 2025-02-14 am EST			5-day change	1st Jan Change
50.18 ^EUR	-0.63%		-1.53%	+1.85%

Feb. 03	Bernstein Upgrades Eurofins Scientific to Outperform, Boosts PT	MT
Jan. 31	EUROFINS SCIENTIFIC : A decent end to FY24: investors jittery with biopharma headwinds

ETFs positioned on Eurofins Scientific SE

Name	Weight	AuM	1st Jan change	Investor Rating
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.47%	33 M€	+3.51%	-
FRANKLIN FTSE FRANCE ETF - USD	0.4%	0 M€	+4.56%	-
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.26%	1,049 M€	+6.21%
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	0.08%	0 M€	-.--%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.07%	33 M€	+5.76%	-
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD	0.05%	0 M€	-3.35%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0.03%	33,076 M€	+4.37%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.02%	366 M€	+2.13%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD	0.02%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR	0.02%	0 M€	-.--%	-
LEVERAGE SHARES PLC - 3X LONG TOTAL WORLD ETP	0.02%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.02%	0 M€	-.--%	-
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.02%	0 M€	-.--%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.01%	619 M€	+2.74%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.01%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.01%	0 M€	+0.04%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	53 M€	+3.55%	-
RAREVIEW SYSTEMATIC EQUITY ETF - USD	0.01%	54 M€	+4.73%	-
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.01%	0 M€	-.--%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR	0.01%	467 M€	+2.66%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	61 M€	+2.75%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR	0.01%	139 M€	+2.13%	-
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD	0.01%	0 M€	+0.11%	-

1 2

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).

Employees

63,000

Sector

Healthcare Facilities & Services

Calendar

2025-04-22 - Q1 2025 Sales and Revenue Release - Trading Update

More about the company